Molecular change in Lysosomal storage disorder is
## Core Concept
Lysosomal storage disorders (LSDs) are a group of genetic disorders caused by deficiencies in lysosomal function, often due to deficiency of a single enzyme required for the metabolism of lipids, glycoproteins, or other molecules. This deficiency leads to accumulation of substrates within lysosomes, disrupting cellular function. The underlying issue in LSDs is related to **lysosomal enzyme deficiency** or **impaired lysosomal function**.
## Why the Correct Answer is Right
The correct answer involves understanding that LSDs primarily result from a deficiency in **lysosomal enzymes**. These enzymes are crucial for breaking down and recycling cellular waste and foreign substances that enter the cell. Without sufficient enzyme activity, substrates accumulate within the lysosomes, leading to cellular dysfunction and disease. This mechanism is fundamental to the pathophysiology of LSDs, which include diseases like Tay-Sachs, Pompe disease, and Gaucher's disease.
## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it does not accurately describe the molecular change in LSDs. While changes in gene expression can lead to LSDs, the direct molecular change is more specifically related to enzyme deficiency.
- **Option B:** This option is incorrect because LSDs are not primarily caused by defects in **cell membrane receptors**. While receptor defects can lead to various diseases, LSDs are specifically related to lysosomal function.
- **Option C:** Although not directly provided, if this option does not relate to enzyme deficiency or function, it would be incorrect for similar reasons as options A and B.
## Clinical Pearl / High-Yield Fact
A key point to remember is that LSDs can often be treated with **enzyme replacement therapy (ERT)**, which involves administering the deficient enzyme to patients. This treatment aims to restore normal lysosomal function and mitigate disease symptoms. LSDs are also sometimes targeted by **substrate reduction therapy**, which aims to decrease the accumulation of substrates by reducing their production.
## Correct Answer: . Deficiency of lysosomal enzyme.